Trio of biotech buyouts jumpstarts J.P. Morgan healthcare meeting — Eisai learns from Biogen’s Aduhelm disaster —5 FDA decisions to watch in the first quarter -- See more on our front page news http://bit.ly/w28kSd #mergersandacquisitions #ipsen #astrazeneca #chiesi #jpm2023 #jpm23 #biogen #eisai #aduhelm #alzheimers #fda #pharma #pharmanews #biopharma #biotech #biotechnology #cafepharma
#mergersandacquisitions #ipsen #astrazeneca #chiesi #jpm2023 #jpm23 #biogen #eisai #aduhelm #alzheimers #FdA #pharma #pharmanews #biopharma #biotech #biotechnology #cafepharma